{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T08:45:35Z","timestamp":1793090735062,"version":"4.5.0"},"reference-count":26,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2022,3,21]],"date-time":"2022-03-21T00:00:00Z","timestamp":1647820800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2022,3,21]],"date-time":"2022-03-21T00:00:00Z","timestamp":1647820800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cardiovasc Intervent Radiol"],"published-print":{"date-parts":[[2022,6]]},"DOI":"10.1007\/s00270-022-03104-3","type":"journal-article","created":{"date-parts":[[2022,3,21]],"date-time":"2022-03-21T21:03:31Z","timestamp":1647896611000},"page":"761-769","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":24,"title":["Drug-Eluting Balloon for Below the Knee Angioplasty: Five-Year Outcome of the DEBATE-BTK Randomized Clinical Trial"],"prefix":"10.1007","volume":"45","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3668-4059","authenticated-orcid":false,"given":"Francesco","family":"Liistro","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matteo Rocco","family":"Reccia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paolo","family":"Angioli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenneth","family":"Ducci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giorgio","family":"Ventoruzzo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giovanni","family":"Falsini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessia","family":"Scatena","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maurizio","family":"Pieroni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leonardo","family":"Bolognese","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,3,21]]},"reference":[{"key":"3104_CR1","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1016\/j.atherosclerosis.2019.09.012","volume":"293","author":"G Agnelli","year":"2020","unstructured":"Agnelli G, Belch JJF, Baumgartner I, Giovas P, Hoffmann U. Morbidity and mortality associated with atherosclerotic peripheral artery disease: a systematic review. Atherosclerosis. 2020;293:94\u2013100.","journal-title":"Atherosclerosis"},{"key":"3104_CR2","doi-asserted-by":"publisher","first-page":"1065","DOI":"10.5603\/KP.2017.0216","volume":"75","author":"V Aboyans","year":"2017","unstructured":"Aboyans V, Ricco JB, Bartelink ML, Bjorck M, Brodmann M, Cohner T, Collet JP, Czerny M, De Carlo M, Debus S, Espinola-Klein C, Kahan T, Kownator S, Mazzolai L, Naylor R, Roffi M, Rother J, Sprynger M, Tendera M, Tepe G, Venermo M. Vlachopoulos C and desormais I [2017 ESC guidelines on the diagnosis and treatment of peripheral arterial diseases, in collaboration with the european society for vascular surgery (ESVS)]. Kardiol Pol. 2017;75:1065\u2013160.","journal-title":"Kardiol Pol"},{"key":"3104_CR3","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1161\/CIRCULATIONAHA.113.001811","volume":"128","author":"F Liistro","year":"2013","unstructured":"Liistro F, Porto I, Angioli P, Grotti S, Ricci L, Ducci K, Falsini G, Ventoruzzo G, Turini F, Bellandi G. Drug-eluting balloon in peripheral intervention for below the knee angioplasty evaluation (DEBATE-BTK) a randomized trial in diabetic patients with critical limb ischemia. Circulation. 2013;128:615\u201321.","journal-title":"Circulation"},{"key":"3104_CR4","doi-asserted-by":"publisher","first-page":"1047","DOI":"10.1002\/ccd.22658","volume":"76","author":"A Schmidt","year":"2010","unstructured":"Schmidt A, Ulrich M, Winkler B, Klaeffling C, Bausback Y, Braunlich S, Botsios S, Kruse HJ, Varcoe RL, Kum S, Scheinert D. Angiographic patency and clinical outcome after balloon-angioplasty for extensive infrapopliteal arterial disease. Catheter Cardiovasc Interv. 2010;76:1047\u201354.","journal-title":"Catheter Cardiovasc Interv"},{"key":"3104_CR5","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1016\/j.jvs.2004.11.041","volume":"41","author":"T Kudo","year":"2005","unstructured":"Kudo T, Chandra FA, Ahn SS. The effectiveness of percutaneous transluminal angioplasty for the treatment of critical limb ischemia: a 10-year experience. J Vasc Surg. 2005;41:423\u201335 (discussion 435).","journal-title":"J Vasc Surg"},{"key":"3104_CR6","doi-asserted-by":"publisher","first-page":"934","DOI":"10.1016\/j.jcin.2018.01.276","volume":"11","author":"S Steiner","year":"2018","unstructured":"Steiner S, Willfort-Ehringer A, Sievert H, Geist V, Lichtenberg M, Del Giudice C, Sauguet A, Diaz-Cartelle J, Marx C, Strobel A, Schult I, Scheinert D, Investigators RS. 12-month results from the first-in-human randomized study of the ranger paclitaxel-coated balloon for femoropopliteal treatment. JACC Cardiovasc Interv. 2018;11:934\u201341.","journal-title":"JACC Cardiovasc Interv"},{"key":"3104_CR7","doi-asserted-by":"publisher","first-page":"e005891","DOI":"10.1161\/CIRCINTERVENTIONS.117.005891","volume":"11","author":"PA Schneider","year":"2018","unstructured":"Schneider PA, Laird JR, Tepe G, Brodmann M, Zeller T, Scheinert D, Metzger C, Micari A, Sachar R, Jaff MR, Wang H, Hasenbank MS, Krishnan P, Investigators IPST. Treatment effect of drug-coated balloons is durable to 3 years in the femoropopliteal arteries: long-term results of the IN PACT SFA randomized trial. Circ Cardiovasc Interv. 2018;11:e005891.","journal-title":"Circ Cardiovasc Interv."},{"key":"3104_CR8","doi-asserted-by":"publisher","first-page":"1102","DOI":"10.1161\/CIRCULATIONAHA.117.028893","volume":"136","author":"P Krishnan","year":"2017","unstructured":"Krishnan P, Faries P, Niazi K, Jain A, Sachar R, Bachinsky WB, Cardenas J, Werner M, Brodmann M, Mustapha JA, Mena-Hurtado C, Jaff MR, Holden AH, Lyden SP. Stellarex drug-coated balloon for treatment of femoropopliteal disease: twelve-month outcomes from the randomized ILLUMENATE pivotal and pharmacokinetic studies. Circulation. 2017;136:1102\u201313.","journal-title":"Circulation"},{"key":"3104_CR9","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1016\/j.eclinm.2019.09.004","volume":"16","author":"C Klumb","year":"2019","unstructured":"Klumb C, Lehmann T, Aschenbach R, Eckardt N, Teichgraber U. Benefit and risk from paclitaxel-coated balloon angioplasty for the treatment of femoropopliteal artery disease: a systematic review and meta-analysis of randomised controlled trials. EClinicalMedicine. 2019;16:42\u201350.","journal-title":"EClinicalMedicine"},{"key":"3104_CR10","doi-asserted-by":"publisher","first-page":"1568","DOI":"10.1016\/j.jacc.2014.06.1198","volume":"64","author":"T Zeller","year":"2014","unstructured":"Zeller T, Baumgartner I, Scheinert D, Brodmann M, Bosiers M, Micari A, Peeters P, Vermassen F, Landini M, Snead DB, Kent KC, Rocha-Singh KJ, Investigators IPDT. Drug-eluting balloon versus standard balloon angioplasty for infrapopliteal arterial revascularization in critical limb ischemia: 12-month results from the IN.PACT DEEP randomized trial. J Am Coll Cardiol. 2014;64:1568\u201376.","journal-title":"J Am Coll Cardiol."},{"key":"3104_CR11","first-page":"205","volume":"31","author":"JA Mustapha","year":"2019","unstructured":"Mustapha JA, Brodmann M, Geraghty PJ, Saab F, Settlage RA, Jaff MR, Lutonix BTKSI. Drug-coated vs uncoated percutaneous transluminal angioplasty in infrapopliteal arteries: six-month results of the lutonix BTK Trial. J Invasive Cardiol. 2019;31:205\u201311.","journal-title":"J Invasive Cardiol."},{"key":"3104_CR12","doi-asserted-by":"publisher","first-page":"e011245","DOI":"10.1161\/JAHA.118.011245","volume":"7","author":"K Katsanos","year":"2018","unstructured":"Katsanos K, Spiliopoulos S, Kitrou P, Krokidis M, Karnabatidis D. Risk of death following application of paclitaxel-coated balloons and stents in the femoropopliteal artery of the leg: a systematic review and meta-analysis of randomized controlled trials. J Am Heart Assoc. 2018;7:e011245.","journal-title":"J Am Heart Assoc."},{"key":"3104_CR13","doi-asserted-by":"publisher","first-page":"2550","DOI":"10.1016\/j.jacc.2019.01.013","volume":"73","author":"PA Schneider","year":"2019","unstructured":"Schneider PA, Laird JR, Doros G, Gao Q, Ansel G, Brodmann M, Micari A, Shishehbor MH, Tepe G, Zeller T. Mortality not correlated with paclitaxel exposure: an independent patient-level meta-analysis of a drug-coated balloon. J Am Coll Cardiol. 2019;73:2550\u201363.","journal-title":"J Am Coll Cardiol"},{"key":"3104_CR14","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1001\/jamacardio.2019.0325","volume":"4","author":"EA Secemsky","year":"2019","unstructured":"Secemsky EA, Kundi H, Weinberg I, Jaff MR, Krawisz A, Parikh SA, Beckman JA, Mustapha J, Rosenfield K, Yeh RW. Association of survival with femoropopliteal artery revascularization with drug-coated devices. JAMA Cardiol. 2019;4:332\u201340.","journal-title":"JAMA Cardiol"},{"key":"3104_CR15","doi-asserted-by":"publisher","first-page":"3732","DOI":"10.1093\/eurheartj\/ehz698","volume":"41","author":"E Freisinger","year":"2019","unstructured":"Freisinger E, Koeppe J, Gerss J, Goerlich D, Malyar NM, Marschall U, Faldum A, Reinecke H. Mortality after use of paclitaxel-based devices in peripheral arteries: a real-world safety analysis. Eur Heart J. 2019;41:3732.","journal-title":"Eur Heart J"},{"key":"3104_CR16","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1016\/j.jvir.2019.11.015","volume":"31","author":"K Katsanos","year":"2020","unstructured":"Katsanos K, Spiliopoulos S, Kitrou P, Krokidis M, Paraskevopoulos I, Karnabatidis D. Risk of death and amputation with use of paclitaxel-coated balloons in the infrapopliteal arteries for treatment of critical limb ischemia: a systematic review and meta-analysis of randomized controlled trials. J Vasc Interv Radiol. 2020;31:202\u201312.","journal-title":"J Vasc Interv Radiol"},{"key":"3104_CR17","doi-asserted-by":"publisher","first-page":"1105","DOI":"10.1016\/j.jacc.2011.05.034","volume":"58","author":"A Schmidt","year":"2011","unstructured":"Schmidt A, Piorkowski M, Werner M, Ulrich M, Bausback Y, Braunlich S, Ick H, Schuster J, Botsios S, Kruse HJ, Varcoe RL, Scheinert D. First experience with drug-eluting balloons in infrapopliteal arteries: restenosis rate and clinical outcome. J Am Coll Cardiol. 2011;58:1105\u20139.","journal-title":"J Am Coll Cardiol"},{"key":"3104_CR18","doi-asserted-by":"publisher","first-page":"694","DOI":"10.1080\/00015458.2009.11680519","volume":"109","author":"V Alexandrescu","year":"2009","unstructured":"Alexandrescu V, Hubermont G, Coessens V, Philips Y, Guillaumie B, Ngongang C, Vincent G, Azdad K, Ledent G, De Marre C, Macoir C. Why a multidisciplinary team may represent a key factor for lowering the inferior limb loss rate in diabetic neuro-ischaemic wounds: application in a departmental institution. Acta Chir Belg. 2009;109:694\u2013700.","journal-title":"Acta Chir Belg"},{"key":"3104_CR19","first-page":"586","volume":"19","author":"A Ciavarella","year":"1993","unstructured":"Ciavarella A, Silletti A, Mustacchio A, Gargiulo M, Galaverni MC, Stella A, Vannini P. Angiographic evaluation of the anatomic pattern of arterial obstructions in diabetic patients with critical limb ischaemia. Diabete Metab. 1993;19:586\u20139.","journal-title":"Diabete Metab"},{"key":"3104_CR20","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1016\/j.carrev.2019.09.001","volume":"21","author":"PA Baghdasaryan","year":"2020","unstructured":"Baghdasaryan PA, Bae JH, Yu W, Rowe V, Armstrong DG, Shavelle DM, Clavijo LC. \u201cThe renal foot\u201d - angiographic pattern of patients with chronic limb threatening ischemia and end-stage renal disease. Cardiovasc Revasc Med. 2020;21:118\u201321.","journal-title":"Cardiovasc Revasc Med"},{"key":"3104_CR21","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1016\/j.ejvs.2006.11.022","volume":"33","author":"L Graziani","year":"2007","unstructured":"Graziani L, Silvestro A, Bertone V, Manara E, Andreini R, Sigala A, Mingardi R, De Giglio R. Vascular involvement in diabetic subjects with ischemic foot ulcer: a new morphologic categorization of disease severity. Eur J Vasc Endovasc Surg. 2007;33:453\u201360.","journal-title":"Eur J Vasc Endovasc Surg"},{"key":"3104_CR22","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1016\/j.jcin.2019.10.059","volume":"13","author":"T Zeller","year":"2020","unstructured":"Zeller T, Micari A, Scheinert D, Baumgartner I, Bosiers M, Vermassen FEG, Banyai M, Shishehbor MH, Wang H, Brodmann M. The IN.PACT DEEP clinical drug-coated balloon trial: 5-year outcomes. JACC Cardiovasc Interv. 2020;13:431\u201343.","journal-title":"JACC Cardiovasc Interv"},{"key":"3104_CR23","doi-asserted-by":"publisher","first-page":"638","DOI":"10.1016\/j.ijcard.2013.04.175","volume":"168","author":"GA Sgueglia","year":"2013","unstructured":"Sgueglia GA, Cortese B, Gaspardone A. Late catch-up phenomenon after drug-eluting balloon angioplasty. Int J Cardiol. 2013;168:638\u20139.","journal-title":"Int J Cardiol"},{"key":"3104_CR24","first-page":"244","volume":"33","author":"F Liistro","year":"2012","unstructured":"Liistro F, Porto I, Grotti S, Angioli P, Brandini R, Ricci L, Ducci K, Falsini G, Tacconi D, Bolognese L. Impact of critical limb ischemia on long term cardiac mortality in diabetic patients undergoing percutaneous coronary revascularization. Eur Heart J. 2012;33:244\u20135.","journal-title":"Eur Heart J"},{"issue":"19","key":"3104_CR25","doi-asserted-by":"publisher","first-page":"2277","DOI":"10.1016\/j.jcin.2020.06.045","volume":"13","author":"F Liistro","year":"2020","unstructured":"Liistro F, Angioli P, Ventoruzzo G, Ducci K, Reccia MR, Ricci L, Falsini G, Scatena A, Pieroni M, Bolognese L. Randomized controlled trial of Acotec drug-eluting balloon versus plain balloon for below-the-knee angioplasty. JACC Cardiovasc Interv. 2020;13(19):2277\u201386.","journal-title":"JACC Cardiovasc Interv"},{"key":"3104_CR26","doi-asserted-by":"crossref","unstructured":"Liistro F, Weinberg I, Popma AA, Shishehbor MH, Deckers S, Micari A. Paclitaxel-coated balloons versus percutaneous transluminal angioplasty for infrapopliteal chronic total occlusions: the IN.PACT BTK randomised trial. EuroIntervention. 2021;EIJ-D-21\u201300444.","DOI":"10.4244\/EIJ-D-21-00444"}],"container-title":["CardioVascular and Interventional Radiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00270-022-03104-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00270-022-03104-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00270-022-03104-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,5,18]],"date-time":"2022-05-18T20:11:10Z","timestamp":1652904670000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00270-022-03104-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,3,21]]},"references-count":26,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2022,6]]}},"alternative-id":["3104"],"URL":"https:\/\/doi.org\/10.1007\/s00270-022-03104-3","relation":{},"ISSN":["0174-1551","1432-086X"],"issn-type":[{"value":"0174-1551","type":"print"},{"value":"1432-086X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,3,21]]},"assertion":[{"value":"3 September 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 February 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 March 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Dr. Francesco Liistro has the following relation to disclose within the last 2\u00a0years: Consultant for Medtronic, Boston scientific and Biotronic. The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"Consent for publication was obtained for every individual person\u2019s data included in the study.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for Publication"}},{"value":"All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and\/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical Approval"}},{"value":"Informed consent was obtained from all individual participants included in the study.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed Consent"}}]}}